Showing results (71-80 of 320) with videos related to
Sort By:
Pageof 32
Nanomedicine : Nanotechnology, Biology, and Medicine|August 20, 2018
Nanoformulations of anticancer FGFR inhibitors with improved therapeutic indexSebastian Kallus, Bernhard Englinger, Julia Senkiv, et al.Pharmaceutics|May 27, 2023
Combination of Drug Delivery Properties of PAMAM Dendrimers and Cytotoxicity of Platinum(IV) Complexes-A More Selective Anticancer Treatment?Yvonne Lerchbammer-Kreith, Michaela Hejl, Petra Vician, et al.Future Oncology (London, England)|October 14, 2011
Lung cancer in never smokersSzilvia Torok, Balazs Hegedus, Viktoria Laszlo, et al.Journal of Structural Biology|October 27, 2010
Chromosomal dynamics of cell cycle regulator gene p21 during transcriptional activationAnatoly A Philimonenko, Jiri Janacek, Luc Snyers, et al.Cancer Chemotherapy and Pharmacology|April 9, 2017
Computed determination of the in vitro optimal chemocombinations of sphaeropsidin A with chemotherapeutic agents to combat melanomasAude Ingels, Carina Dinhof, Abhishek D Garg, et al.The Journal of Steroid Biochemistry and Molecular Biology|March 18, 2015
Effect of 1,25-dihydroxyvitamin D3 on the Wnt pathway in non-malignant colonic cellsCharlotte Gröschel, Abhishek Aggarwal, Samawansha Tennakoon, et al.Dalton Transactions (Cambridge, England : 2003)|April 8, 2016
Another step toward DNA selective targeting: Ni(II) and Cu(II) complexes of a Schiff base ligand able to bind gene promoter G-quadruplexesAlessio Terenzi, Daniela Lötsch, Sushilla van Schoonhoven, et al.Journal of Experimental & Clinical Cancer Research : CR|November 4, 2015
EGFR is not a major driver for osteosarcoma cell growth in vitro but contributes to starvation and chemotherapy resistanceFlorian Sevelda, Lisa Mayr, Bernd Kubista, et al.Chemistry & Biodiversity|December 20, 2018
Synthesis, Characterization and in vitro Studies of a Cathepsin B-Cleavable Prodrug of the VEGFR Inhibitor SunitinibClaudia Karnthaler-Benbakka, Bettina Koblmüller, Marlene Mathuber, et al.Biochemical and Biophysical Research Communications|May 27, 2009
Interaction between fatty acid synthase- and ErbB-systems in ovarian cancer cellsThomas W Grunt, Renate Wagner, Michael Grusch, et al.Pageof 32